About Rayzebio, Inc. 
Rayzebio, Inc.
Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 25 Schemes (10.08%)
Foreign Institutions
Held by 32 Foreign Institutions (6.53%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Sep 2023)
Net Profit:
-18 Million
Biotechnology
USD 3,814 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-0.94
-11.92%
6.63






